Comparative analysis of formyl peptide receptor 1 and formyl peptide receptor 2 reveals shared and preserved signalling profiles
This article is part of a themed issue Drugs and Drug Targets in Metabolic and Chronic Inflammatory Diseases. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v182.20/issuetoc.
Authors
- Marcel Bermúdez (ORCID: https://orcid.org/0000-0002-7421-3282)
- Oliver Soehnlein (ORCID: https://orcid.org/0000-0002-7854-0694)
- Carsten A. Raabe (ORCID: https://orcid.org/0000-0003-3514-4840)
- Ursula Rescher (ORCID: https://orcid.org/0000-0001-8892-319X)
- Denise Pajonczyk (ORCID: https://orcid.org/0000-0001-8413-1646)
- Merle F. Sternschulte
Institutions
- University of Münster (DE)
- Institute of Molecular Biology (DE)
Publication Details
- Journal
- British Journal of Pharmacology
- Published
- 2024-09-18
- DOI
- https://doi.org/10.1111/bph.17334
- Citations
- 9
- Primary Topic
- S100 Proteins and Annexins
- Type
- article
- Field-Weighted Citation Impact
- 2.10
Funders
- Deutsche Forschungsgemeinschaft
- Novo Nordisk